Cardiac Valve Diseases and Treatments
Moving in medRxiv, bioRxiv, New England Journal of Medicine, Circulation.
- Moved this week
- 0
Rebuilt
Moved this week
Nothing in this area has moved yet this week.
Latest in Cardiac Valve Diseases and Treatments
Newest first · last 60 days
Timely diagnosis and treatment of aortic stenosis improved modestly from 2023 to 2024 but remain suboptimal, with only 54-61% diagnosed within 30 days at a national level.
Performing TAVI before PCI is noninferior to PCI before TAVI regarding 1-year outcomes in patients with severe aortic stenosis and coronary artery disease, with a 22.2% versus 24.2% event rate.
Transcatheter tricuspid-valve repair significantly reduces death and hospitalization risks in patients with severe tricuspid regurgitation, with a win ratio of 2.42 at 1 year.
Browse JClub
Journals this month
- bioRxiv5569
- medRxiv1746
- Environ Res483
- PNAS463
- Sci Adv439
- JAMA255
- Cell Rep210
- BMJ199
- Nat Commun177
- Environ Pollution170
- Lancet149
- Science138
- NEJM119
- Applied & Environ Microbio116
- J Exp Bot115
- Curr Biol112
- mBio109
- Nature104
Moving areas, week to 3 Oct 2026
- Single-cell and spatial transcriptomics10
- Artificial Intelligence in Healthcare and Education8
- CAR-T cell therapy research7
- Neuroinflammation and Neurodegeneration Mechanisms6
- Lung Cancer Treatments and Mutations5
- Diabetes Treatment and Management4
- Pancreatic and Hepatic Oncology Research4
- Photosynthetic Processes and Mechanisms4
- Genomics and Chromatin Dynamics4
- Gut microbiota and health4